SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 128 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $307,000 | -67.7% | 10,361 | -57.9% | 0.01% | -43.8% |
Q4 2015 | $949,000 | +102.8% | 24,592 | +68.7% | 0.02% | +100.0% |
Q3 2015 | $468,000 | +127.2% | 14,580 | +115.4% | 0.01% | +100.0% |
Q2 2015 | $206,000 | -29.0% | 6,768 | -30.6% | 0.00% | -20.0% |
Q2 2014 | $290,000 | -16.9% | 9,748 | -43.2% | 0.01% | +25.0% |
Q4 2013 | $349,000 | +50.4% | 17,163 | +249.6% | 0.00% | +33.3% |
Q3 2013 | $232,000 | – | 4,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |